Cost of Care for Newborns With Neonatal Abstinence Syndrome in a State Medicaid Program

Overview

Journal JAMA Netw Open

Publisher American Medical Association

Specialty General Medicine

Date 2024 Feb 26

PMID 38407906

Authors

Caroline Jenkins

Matthew Hudnall

Courtney Hanson

Dwight Lewis

Jason M Parton

Affiliations

Soon will be listed here.

Abstract

Importance: Neonatal abstinence syndrome (NAS) is a medical condition among neonates experiencing substance withdrawal due to the mother's substance use during pregnancy. While previous studies suggest that the overall incidence and annual costs of NAS are increasing, to date, the long-term costs have yet to be demonstrated in Medicaid populations.

Objective: To examine the demographic differences and long-term costs of care for neonates diagnosed with vs not diagnosed with NAS.

Design, Setting, And Participants: This cohort study used claims data from the Alabama Medicaid Agency for neonates born to Medicaid-eligible mothers between January 1, 2010, and December 31, 2020. Data were analyzed in June 2022.

Exposure: A diagnosis of NAS within 30 days of birth.

Main Outcomes And Measures: Rate of NAS by demographic and birth characteristics, long-term costs attributable to NAS status and demographic and birth characteristics, and distribution of this expenditure over the enrollment period.

Results: A total of 346 259 neonates with Medicaid eligibility were born during the study period (mean [SD] gestational age, 38.4 [2.2] weeks; 50.5%, male), 4027 (1.2%) of whom had an NAS diagnosis within 30 days of birth. A larger percentage of neonates with an NAS diagnosis were male (52.7%) than in the group without NAS (50.5%). Neonates with NAS also weighed less at birth (mean difference, -212.0 g; 95% CI, -231.1 to -192.8 g) and had older mothers (mean difference, 3.4 years; 95% CI, 2.6-4.2 years). An NAS diagnosis had an estimated additional cost of $17 921 (95% CI, $14 830-$21 012) over the enrollment period, and this cost was not evenly distributed over that period.

Conclusions And Relevance: In this cohort study of neonates born into the Alabama Medicaid population, those with an NAS diagnosis had a different demographic profile and a higher cost to state Medicaid agencies than those without NAS. These findings warrant further effort to reduce the occurrence of NAS.

References

Hirai A, Ko J, Owens P, Stocks C, Patrick S . Neonatal Abstinence Syndrome and Maternal Opioid-Related Diagnoses in the US, 2010-2017. JAMA. 2021; 325(2):146-155. PMC: 7804920. DOI: 10.1001/jama.2020.24991. View

Patrick S, Schumacher R, Benneyworth B, Krans E, McAllister J, Davis M . Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. JAMA. 2012; 307(18):1934-40. DOI: 10.1001/jama.2012.3951. View

Dunn A, Grosse S, Zuvekas S . Adjusting Health Expenditures for Inflation: A Review of Measures for Health Services Research in the United States. Health Serv Res. 2016; 53(1):175-196. PMC: 5785315. DOI: 10.1111/1475-6773.12612. View

Corr T, Xing X, Liu G . Longitudinal Health Care Utilization of Medicaid-Insured Children with a History of Neonatal Abstinence Syndrome. J Pediatr. 2021; 233:82-89.e1. DOI: 10.1016/j.jpeds.2021.01.067. View

Pagano E, Petrelli A, Picariello R, Merletti F, Gnavi R, Bruno G . Is the choice of the statistical model relevant in the cost estimation of patients with chronic diseases? An empirical approach by the Piedmont Diabetes Registry. BMC Health Serv Res. 2015; 15:582. PMC: 4696194. DOI: 10.1186/s12913-015-1241-1. View

Nygaard E, Slinning K, Moe V, Walhovd K . Behavior and Attention Problems in Eight-Year-Old Children with Prenatal Opiate and Poly-Substance Exposure: A Longitudinal Study. PLoS One. 2016; 11(6):e0158054. PMC: 4918960. DOI: 10.1371/journal.pone.0158054. View

Winkelman T, Villapiano N, Kozhimannil K, Davis M, Patrick S . Incidence and Costs of Neonatal Abstinence Syndrome Among Infants With Medicaid: 20042014. Pediatrics. 2018; 141(4). PMC: 5869343. DOI: 10.1542/peds.2017-3520. View

Goyal S, Saunders K, Moore C, Fillo K, Ko J, Manning S . Identification of Substance-Exposed Newborns and Neonatal Abstinence Syndrome Using ICD-10-CM - 15 Hospitals, Massachusetts, 2017. MMWR Morb Mortal Wkly Rep. 2020; 69(29):951-955. PMC: 7377822. DOI: 10.15585/mmwr.mm6929a2. View

Benningfield M, Arria A, Kaltenbach K, Heil S, Stine S, Coyle M . Co-occurring psychiatric symptoms are associated with increased psychological, social, and medical impairment in opioid dependent pregnant women. Am J Addict. 2010; 19(5):416-21. PMC: 2924760. DOI: 10.1111/j.1521-0391.2010.00064.x. View

10.

Appleton A, Holdsworth E, Kubzansky L . A Systematic Review of the Interplay Between Social Determinants and Environmental Exposures for Early-Life Outcomes. Curr Environ Health Rep. 2016; 3(3):287-301. DOI: 10.1007/s40572-016-0099-7. View

11.

Spiller H, Lorenz D, Bailey E, Dart R . Epidemiological trends in abuse and misuse of prescription opioids. J Addict Dis. 2009; 28(2):130-6. DOI: 10.1080/10550880902772431. View

12.

Patrick S, Davis M, Lehmann C, Lehman C, Cooper W . Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012. J Perinatol. 2015; 35(8):650-5. PMC: 4520760. DOI: 10.1038/jp.2015.36. View

13.

Liu G, Kong L, Leslie D, Corr T . A Longitudinal Healthcare Use Profile of Children with a History of Neonatal Abstinence Syndrome. J Pediatr. 2018; 204:111-117.e1. DOI: 10.1016/j.jpeds.2018.08.032. View

14.

Corr T, Hollenbeak C . The economic burden of neonatal abstinence syndrome in the United States. Addiction. 2017; 112(9):1590-1599. DOI: 10.1111/add.13842. View

15.

van Baar A, de Graaff B . Cognitive development at preschool-age of infants of drug-dependent mothers. Dev Med Child Neurol. 1994; 36(12):1063-75. DOI: 10.1111/j.1469-8749.1994.tb11809.x. View

16.

Kocherlakota P . Neonatal abstinence syndrome. Pediatrics. 2014; 134(2):e547-61. DOI: 10.1542/peds.2013-3524. View